Kroon AA - Search Results

1

de Leeuw PW, Kroon AA. de Leeuw PW, et al. Among authors: kroon aa. Hypertension. 2013 Sep;62(3):461-2. doi: 10.1161/HYPERTENSIONAHA.113.01831. Epub 2013 Jul 29. Hypertension. 2013. PMID: 23897072 No abstract available.

2

Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertension.

de Leeuw PW, Kroon AA. de Leeuw PW, et al. Among authors: kroon aa. J Hypertens Suppl. 1997 Mar;15(2):S39-42. J Hypertens Suppl. 1997. PMID: 9218197 Review.

3

What goes up, must come down: treating the hypertensive emergency.

de Leeuw PW, Kroon AA. de Leeuw PW, et al. Among authors: kroon aa. Eur J Clin Pharmacol. 1998 Jun;54(4):277-9. doi: 10.1007/s002280050459. Eur J Clin Pharmacol. 1998. PMID: 9696949 No abstract available.

4

Hypertension and the development of heart failure.

de Leeuw PW, Kroon AA. de Leeuw PW, et al. Among authors: kroon aa. J Cardiovasc Pharmacol. 1998;32 Suppl 1:S9-15. doi: 10.1097/00005344-199800003-00003. J Cardiovasc Pharmacol. 1998. PMID: 9731690 Review.

5

[The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease].

Spiering W, Kroon AA, Vreugdenhil HA, Geraedts JP, Daemen MJ, de Leeuw PW. Spiering W, et al. Among authors: kroon aa. Ned Tijdschr Geneeskd. 1998 Jun 20;142(25):1445-50. Ned Tijdschr Geneeskd. 1998. PMID: 9752056 Review. Dutch.

6

Adenosine-induced renal vasodilatation is prolonged in renal artery stenosis.

Wierema TK, Postma CT, Houben AJ, Kroon AA, Thien T, Smits P, de Leeuw PW. Wierema TK, et al. Among authors: kroon aa. J Hypertens. 1998 Dec;16(12 Pt 2):2109-12. J Hypertens. 1998. PMID: 9886904

7

Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.

van der Zander K, Houben AJ, Kroon AA, de Leeuw PW. van der Zander K, et al. Among authors: kroon aa. Cardiovasc Res. 1999 Dec;44(3):595-600. doi: 10.1016/s0008-6363(99)00234-5. Cardiovasc Res. 1999. PMID: 10690292 Clinical Trial.

8

Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension.

Lavrijssen AT, Kroon AA, Fuss-Lejeune M, Schiffers PM, de Leeuw PW. Lavrijssen AT, et al. Among authors: kroon aa. J Hypertens. 2000 Jul;18(7):963-9. doi: 10.1097/00004872-200018070-00019. J Hypertens. 2000. PMID: 10930195 Clinical Trial.

9

Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet.

Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW. Spiering W, et al. Among authors: kroon aa. Hypertension. 2000 Sep;36(3):411-6. doi: 10.1161/01.hyp.36.3.411. Hypertension. 2000. PMID: 10988274

10

Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.

Houben AJ, Kroon AA, de Haan CH, Fuss-Lejeune MJ, de Leeuw PW. Houben AJ, et al. Among authors: kroon aa. Cardiovasc Drugs Ther. 2000 Dec;14(6):657-63. doi: 10.1023/a:1007875100562. Cardiovasc Drugs Ther. 2000. PMID: 11300367 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters